https://pittplusme.org/study/2132
SPARX3: Study in Parkinson Disease of Exercise Phase 3 Clinical Trial
STUDY BASICS
Are you 40-80 years old and have been diagnosed with Parkinson’s disease (PD) within the past 3 years? You may be able to participate in a study looking at how exercise affects the progression of PD symptoms. Eligible participants are not taking medication for PD symptoms. Study participation involves engaging in exercise 4 times/week for 18 months. Compensation is provided for evaluation visits.
IRB: STUDY20110328
- sIRB SPARX3: Study in Parkinson Disease of Exercise, Phase 3 Clinical Trial
AGE:
40-80
DURATION:
24 months
VISITS:
Multiple
LOCATION:
Kaufmann Building, UPMC Montefiore & Presbyterian Hospitals & Physical Therapy – Clinical and Translational Research Center (PT-CTRC)
COMPENSATION:
$300
SHARE STUDY
